Nanomedicine Has Opened New Avenues for Cancer Diagnosis and Therapy

Zhifei Dai
DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0069
2016-01-01
Abstract:Professor Zhi-Fei Dai obtained his Ph.D. degree at Chinese Academy of Sciences in Beijing. He is now a professor at Biomedical Engineering Department, Peking University. His research is focused on contrast agent, nanomedicine and molecular imaging. He is a chief scientist for National Key Research and Development Program of China. He works as a member of editorial board for several international and national journals such as Bioconjugate Chemistry, Theranostics, Journal of Interdisciplinary Nanomedicine, IET Nanobiotechnology, Chinese Journal of Nuclear Medicine and Molecular Imaging and so on. He is now serving as a vice chairman in Chinese Society of Biomedical Engineering in Photonics, a standing committee member in Ultrasound Molecular Imaging, Chinese Association of Ultrasound in Medicine and Engineering, an executive member of the council in Chinese Society for Functional Materials, and a committee member in the Biomedical Engineering in Ultrasonics, the Acoustic Society of China. He received honors and awards including National Natural Science Foundation for Outstanding Young Researcher, New Century Talents by Chinese Ministry of Education, Longjiang Scholarship Distinguished Professor, and the First Prize for Natural Sciences in Heilongjiang Province.
What problem does this paper attempt to address?